S&P 500 Futures Up In Premarket Trading; Amgen, ImmunityBio Lead

Dow Jones05-03

This article was automatically generated by Barrons.com using technology from Automated Insights.

With U.S. stock markets set to open in two hours, Amgen Inc. $(AMGN)$ was up 13.6% in pre-market trading, and ImmunityBio Inc. $(IBRX)$ was up 7.9%.

Block Inc. $(SQ)$, XPO Inc. $(XPO)$, and Apple Inc. $(AAPL)$ were all posting gains of at least 6%. In early trading, Cloudflare Inc. Cl A $(NET)$ and Expedia Group Inc. (EXPE) had posted declines, falling 12.9% and 11.5%, respectively.

Meanwhile S&P 500 futures were up 0.36%, with futures for the Dow Jones Industrial Average rising 0.75%. The Cboe Volatility Index futures were down 4.52%.

In commodities news, Brent crude oil futures were up 0.36%, and gold futures were down 0.10%. Bitcoin was down 0.25% to $59,189.

The 10-Year Treasury yield dropped to 4.569%.

In the previous regular trading session, the S&P 500 and the Dow were up 0.91% and 0.85%, respectively.

In afternoon trading, stocks in Europe are up, with the STOXX Europe 600 Index rising 0.36% and the FTSE 100 Index increasing 0.46% from the previous close.

U.S. stock markets open for trading at 9:30 a.m. ET.

Data source: Dow Jones Market Data, FactSet. Data compiled May 03, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

May 03, 2024 07:31 ET (11:31 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment